Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.084
Sell
RSI(14)
22.101
Sell
STOCH(KDJ)(9,3,3)
23.173
Buy
ATR(14)
0.154
High Vlolatility
CCI(14)
-49.268
Neutral
Williams %R
95.585
Oversold
TRIX(12,20)
-5.441
Sell
StochRSI(14)
33.889
Sell
Agape ATP Corp
ATPC0.111USD
+0.003+2.78%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
5.56MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Agape ATP Corp
Currency: USD Updated: 2025-12-24Key Insights
Agape ATP Corp's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 152/206 in the Healthcare Equipment & Supplies industry.Institutional ownership is low.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Agape ATP Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Agape ATP Corp Highlights
StrengthsRisks
Agape ATP Corporation is a Malaysia-based investment holding company. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging, and products designed to improve the overall health system of the human body, along with various wellness programs. The Company offers three series of programs, each consisting of different services and products: ATP Zeta Health Program, ENERGETIQUE, and BEAUNIQUE. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake, and unhealthy lifestyles. The ENERGETIQUE series consists of energy mask series, hyaluronic acid, and mousse facial cleanser. Its BEAUNIQUE product series focuses on researching diet’s impact on modifying gene expressions to address genetic variations and deliver a nutrigenomic solution for every individual.
Growing
The company is in a growing phase, with the latest annual income totaling USD 1.32M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.32M.
Overvalued
The company’s latest PE is -0.43, at a high 3-year percentile range.
Financial Health
Currency: USD Updated: 2025-12-24The current financial score of Agape ATP Corp is 6.13, ranking 173/206 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 370.59K, representing a year-over-year increase of 11.86%, while its net profit experienced a year-over-year increase of 15.15%.
Score
Financials
6.29
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
6.84
Operational Efficiency
4.62
Growth Potential
5.81
Shareholder Returns
7.07
Agape ATP Corp's Company Valuation
Currency: USD Updated: 2025-12-24The current valuation score of Agape ATP Corp is 6.73, ranking 156/206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.43, which is -38.45% below the recent high of -0.27 and -17636.18% above the recent low of -76.57.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 152/206
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-24No earnings forecast score is currently available for Agape ATP Corp. The Healthcare Equipment & Supplies industry's average is 7.77.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
No Data
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-24The current price momentum score of Agape ATP Corp is 5.56, ranking 173/206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 1.04 and the support level at -0.38, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
0.120
Sell
MA10
0.126
Sell
MA20
0.643
Sell
MA50
1.011
Sell
MA100
1.148
Sell
MA200
1.346
Sell
Institutional Confidence
Currency: USD Updated: 2025-12-24Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2025-12-24The current risk assessment score of Agape ATP Corp is 3.25, ranking 128/206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
--
VaR
--
240-Day Maximum Drawdown
+97.22%
240-Day Volatility
+242.43%
Return
Best Daily Return
60 days
+164.56%
120 days
+164.56%
5 years
--
Worst Daily Return
60 days
-94.83%
120 days
-94.83%
5 years
--
Sharpe Ratio
60 days
+0.50
120 days
+0.32
5 years
--
Risk Assessment
Maximum Drawdown
240 days
+97.22%
3 years
--
5 years
--
Return-to-Drawdown Ratio
240 days
-0.94
3 years
--
5 years
--
Skewness
240 days
+4.48
3 years
--
5 years
--
Volatility
Realised Volatility
240 days
+242.43%
5 years
--
Standardised True Range
240 days
+135.52%
5 years
--
Downside Risk-Adjusted Return
120 days
+47.12%
240 days
+47.12%
Maximum Daily Upside Volatility
60 days
+389.57%
Maximum Daily Downside Volatility
60 days
+248.50%
Liquidity
Average Turnover Rate
60 days
+0.10%
120 days
+1.31%
5 years
--
Turnover Deviation
20 days
--
60 days
--
120 days
--
Peer Comparison
Healthcare Equipment & Supplies
Agape ATP Corp
ATPC
4.28 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
EW
8.69 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
AORT
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
TCMD
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AXGN
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of Agape ATP Corp?
The TradingKey Stock Score provides a comprehensive assessment of Agape ATP Corp based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Agape ATP Corp’s performance and outlook.
How do we generate the financial health score of Agape ATP Corp?
To generate the financial health score of Agape ATP Corp, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects Agape ATP Corp's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Agape ATP Corp.
How do we generate the company valuation score of Agape ATP Corp?
To generate the company valuation score of Agape ATP Corp, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Agape ATP Corp’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Agape ATP Corp’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Agape ATP Corp.
How do we generate the earnings forecast score of Agape ATP Corp?
To calculate the earnings forecast score of Agape ATP Corp, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Agape ATP Corp’s future.
How do we generate the price momentum score of Agape ATP Corp?
When generating the price momentum score for Agape ATP Corp, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of Agape ATP Corp’s prices. A higher score indicates a more stable short-term price trend for Agape ATP Corp.
How do we generate the institutional confidence score of Agape ATP Corp?
To generate the institutional confidence score of Agape ATP Corp, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Agape ATP Corp’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Agape ATP Corp.
How do we generate the risk management score of Agape ATP Corp?
To assess the risk management score of Agape ATP Corp, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of Agape ATP Corp’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Agape ATP Corp.
